Catalyst Pharmaceuticals, Inc. (CPRX) has a market capitalization of $3.22B and trades at $26.19. The 52-week range is 19.05-26.58.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 15, Earnings Per Share (EPS) of $1.75, annual revenue of $588.99M.
The stock has a beta of 0.66, operates in the Healthcare sector.
